<正>Acetylcholinesterase(AChE)inhibitors,which enhance cholinergic transmission by reducing the enzymatic degradation of acetylcholine,are the only source of the compound that is currently approved for the treatment of Alzheimer's disease(AD).For the purpose of developing new